Clinical Trials Logo

Clinical Trial Summary

Pain after anterior cruciate ligament reconstruction with autologous hamstring graft can be attributed to both arthroscopic surgery and the graft donor site. Many methods are available to provide postoperative analgesia for patients undergoing total knee arthroplasty, but it is unclear how they compare with each other. The extent to which the two techniques anterior division obturator nerve block vs peritendinous hamstring injection may benefit the patients in terms of overall analgesia and specifically the autograft site analgesia needs evaluation.


Clinical Trial Description

In induction room, standard anesthesia monitors, including Electrocardiogram, Non Invasive Blood Pressure, and pulse oximeter, will be connected. Baseline parameters such as mean arterial pressure, heart rate, and oxygen saturation will be recorded. An intravenous cannula of 18-gauge will be secured and intravenous lactated Ringer will be started, for all patients. The patients will be premedicated with Midazolam 0.02 mg/kg, fentanyl 50-100 μg IV titrated to effect, Granisetron 1 mg (undiluted) Intravenous push over 30 seconds and Proton pump inhibitor 40 mg. Patients will be placed in the supine position with the operative leg externally rotated. Asepsis will be achieved using chlorhexidine 2% in alcohol. The skin at block sites will be subsequently infiltrated with lidocaine 2%. In group C: (n=26) every patient will receive unilateral adductor canal block alone, a pre-procedural scan using a 5 cm (7-13 MHz) high-frequency linear transducer will be performed to identify the location of the descending genicular artery arising from the superficial femoral artery. The finding of this vascular landmark is known to demark the exit (and subsequent bifurcation) of the saphenous nerve from the adductor canal just distal to the discontinuation of the vaso-adductor membrane. The injection point for the ACB will be 2 cm proximal to this landmark along the sartorius muscle. A 21-gauge 90 mm needle will pass in-plane in an anterolateral to posteromedial direction through the sartorius muscle. Once the needle tip location is confirmed (by hydro-location using dextrose 5%, 1-2 ml) to be lateral to the femoral artery but within the adductor canal, bupivacaine 0.25%, 20 ml will be injected after negative aspiration for blood . In group H: (n=26) every patient will receive unilateral peri-hamstring injection combined to adductor canal block, After the completion of the Adductor canal block, the transducer will be moved further posteriorly around the thigh. The same needle will be redirected in a steeper posteromedial direction towards the fascial plane between the sartorius and gracilis muscle. Once the needle tip is confirmed to be deep to sartorius but superficial to gracilis, bupivacaine 0.25%, 7.5 ml will be injected superficially to the deep fascia of the muscle sheath to achieve free spread around the anterior surface of the muscle contained within the fascial compartment (as the muscle was viewed in short axis on ultrasound). The needle will then be advanced further posteriorly towards the fascial planes between the semimembranosus and semitendinosus, and an additional bupivacaine 0.25%, 7.5 ml will be similarly injected to achieve spread around the anterior aspect of the semitendinosus muscle superficial to its deep fascia . In group O: (n=26) every patient will receive unilateral anterior obturator nerve block combined to adductor canal block, The anterior branch of the obturator nerve is seen in the proximal thigh medial to the femoral vessels between the adductor longus and adductor brevis below the inguinal crease. The same 21-gauge 90 mm needle will be directed through the adductor longus in an out of plane technique. A small volume of dextrose 5%, (1-2 ml) will be injected to ensure the needle tip is positioned between the two muscles. After negative aspiration, bupivacaine 0.25%, 10 ml will be injected in this muscle plane to surround the anterior division of obturator nerve. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06398717
Study type Interventional
Source Ain Shams University
Contact Mohamed Ibrahim El-Desoukey, Master degree
Phone 0201064988842
Email mohamed.i.eldesoukey@med.asu.edu.eg
Status Not yet recruiting
Phase N/A
Start date May 1, 2024
Completion date January 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT05960422 - Popliteal Sciatic Nerve Block and Adductor Canal Block N/A
Not yet recruiting NCT05587166 - Ultrasound-Guided Oblique Short-Axis Adductor Canal Block. N/A
Recruiting NCT05518513 - Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty N/A
Recruiting NCT06402110 - Femoral Triangle Block Versus Adductor Canal Block in Arthroscopic Anterior Cruciate Ligament Reconstruction N/A
Completed NCT02125903 - Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy N/A
Completed NCT03008564 - Adductor Canal Block Ultrasound Anatomy in Volunteers N/A
Completed NCT04968392 - Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty Phase 2/Phase 3
Recruiting NCT05742958 - The Quality of Recovery After Intrathecal Morphine or Adductor Canal Block in Anterior Cruciate Ligament Reconstruction Phase 4
Recruiting NCT05981105 - Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty N/A
Completed NCT02554864 - Location of Injection of Local Anesthetics in the Adductor Canal Block N/A
Completed NCT02991404 - Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty Early Phase 1
Withdrawn NCT04539730 - Liposomal Bupivacaine in Adductor Canal Blocks (ACB) Phase 4
Not yet recruiting NCT03486548 - Analgesic Efficacy of Adding SCB With Low Concentration Bupivacaine Combined With Dexamethasone on Pain After TKA Phase 4